Electromed PE ratio ELMD

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 20.1×
10-year median: 29.0×
Against its 10-year history: 4th; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.3× to 58.9×
Peer median: 18.9×

Electromed's PE ratio is 20.1× as of Oct 23, 2026: a share price of $26.37 against $1.31 of earnings per share over the last twelve months.

That is below its ten-year median of 29.0×, lower than on 96% of days in the last ten years.

Over that time it ranged from 14.3× in Nov 2016 to 58.9× in Mar 2022.

The median for 10 healthcare stocks of a similar size is 18.9×.

PE ratio over time

median 29×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.1×	20.1×	39.0×
2025	30.6×	22.9×	47.8×
2024	40.6×	27.8×	43.9×
2023	29.5×	27.7×	58.1×
2022	47.7×	34.6×	58.9×
2021	52.0×	24.1×	52.5×
2020	23.9×	17.7×	39.2×
2019	26.0×	21.1×	30.5×
2018	22.0×	22.0×	30.3×
2017	24.3×	15.0×	36.7×
2016	15.5×	13.5×	24.8×
2015	15.8×	11.7×	128×
2014	n/m a value too high to mean anything
2013	n/m a value too high to mean anything
2012	71.0×	67.0×	84.0×

Against its peers

Companies in Healthcare nearest Electromed's size, closest first, today.

Company	PE ratio
ELMDElectromed	20.1×
NATRNatures Sunshine Products	12.0×
UTMDUtah Medical Products	22.6×
PLXProtalix BioTherapeutics	11.1×
PDEXPro DEX	15.1×
INFUInfuSystem	34.0×
VMDViemed Healthcare	27.2×
EMBCEmbecta	4.6×
ARVNArvinas	45.6×
NRCNRC Health	87.7×
KEQUKewaunee Scientific	11.9×
Peer median	18.9×

Where Electromed ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Electromed

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.